GFAN Key Messages from the Global Fund Results Report 2026

Global Fund’s 2026 Results Report Highlights “Seismic Year” of Unprecedented Risks to Hard-Won Gains in the Fights Against HIV, TB, and Malaria

This page highlights the Report’s key numbers and messages. Our reading guide provides more depth in numbers, messages, and context.

The Global Fund’s 2026 Results Report is out. The warning in its key messages couldn’t be clearer: “an abrupt and far-reaching cuts in international funding disrupted critical lifesaving services and put hard-won progress against HIV, TB, and malaria at risk”.

The report paints a picture of an unequal impact of the cuts; some countries faced limited disruption and are highlighted as examples of resilience while others have seen significant impact.

For GFAN members, the report’s scope will be familiar: the results achieved collectively through all international and domestic funding channels in countries where the Global Fund supports. So will the results captured: annual volume of services delivered by the Partnership, and an estimation of the scale of the Partnership’s historical impact since 2002.

First, the headline numbers:

These figures capture the services delivered via the full Partnership—domestic and international funding—in countries where the Global Fund supports a disease response.

Twenty Years of Momentum and Millions of Lives, Now at Risk

If the Partnership’s impact on one life alone can be difficult to capture in words, the sheer scale of the Partnership’s response makes linking figures to real-world specific impact all the more important (a point at the front of mind as I head to meet our new Speakers Bureau). The report’s cover photo of a smiling woman holding a baby offers its own poignant reminder of the stakes of health, and provokes our curiosity: which of the essential pediatric services covered by the Global Fund, and now at risk, might the baby need? And is she the caretaker or healthcare provider? We learned on the GFAN call that her name is Angelica, a nurse in Mozambique at a clinic for women living with HIV.

The report also gives us the historical numbers:

72 million lives saved since the Global Fund’s founding in 2002.
This is the result of a 65% drop in combined death rates from HIV, TB and malaria

The Results Report highlights the major risk of reversals in two decades of progress in HIV, a rebound in TB after a resilient recovery from TB, and a risk of a decade-long rebound in malaria spiraling further.

These are the hard-won gains, achieved through steady expansion of service coverage and quality—all achieved amidst a decade-long funding plateau in the face of constantly growing populations at risk.

The funding cuts risk steering us further away from the 2030 goals just as that year approaches; moreover, cuts in funding have taken place just as a wave of exciting new technologies are in various stages of scale up: dual-insecticide treated nets for malaria, lenacapavir for HIV prevention, and near point-of-care TB testing.

After years of reports that measured incremental progress against a stable backdrop, the 2026 Results Report measures the first time so many indicators are moving in the wrong direction across the three diseases. These cracks in the response can sometimes show up in programmatic data before the reversals appear in the impact data; and for TB and malaria, where the WHO’s estimates of deaths and cases for 2025 have yet to be released, it is only next year that we will have a full picture of the impact. Even for countries that showed resilience in 2025, we cannot assume that cracks won’t open under sustained pressure or that cracks wouldn’t become visible if we could look closer—e.g. testing numbers are up, but what about positive cases found?

A Different Kind of Advocacy Year

Past Results Reports were a testament to the success of the Partnership model. And recent years described the Global Fund’s remarkable resilience in the face of Covid-19. The tone of this report is different. On top of external challenges in the fight against the three diseases, this one highlights an unprecedented internal shock.

This report notes that its estimation of the share of the Global Fund’s contribution to international funding across each disease reflects 2024 data; in that context, it’s important to note that recent and expected annual declines in bilateral assistance are likely to steadily increase the Global Fund’s share of resource contributions across all three diseases in coming years.

Amidst contracting resources and evolving architectures, it remains our challenge to not only sustain funding in the disease responses, but also to highlight why the Partnership’s core values have been so crucial to its success in converting investments into impact.

We have to trace in bright colors the link between the countable data and the non-countable norms and values that civil society and communities have long promoted. We must now defend and mobilize solidarity around them!

Our Social Media Toolkit

Click on the images to download. You can tag us on X ( Formerly Twitter ) and Facebook @GFAdvocates.